Vimarsana
Biggest News Aggregation in the World

Alpharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpharma Inc Today - Breaking & Trending Today

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies - Vimarsana News

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Published: November 24, 2023

Processa Pharmaceuticals’ (NASDAQ: PCSA) shares skyrocketed by over 260% from their October lows of $0.18 per share. Shares peaked at $0.65 on November 14th and more recently has consolidated around $0.43. The reason for this surge was not immediately clear given the lack of material  events. However upon digging deeper, we’ve uncovered a very interesting […]

Source: microcapdaily.com
Related Topics:
David YoungSpectrum Pharmaceuticals IncManagement TeamQuestcor PharmaceuticalsBiodelivery Sciences International IncScilex Holding CoResearch DevelopmentSorrento Therapeutics IncUniversity Of Maryland School PharmacyScilex Pharmaceuticals IncPfizer IncAlpharma IncNational Cancer InstituteProcessa PharmaceuticalAdverse EventsRight NowScilex PharmaceuticalsSorrento TherapeuticsBiodelivery Sciences InternationalSpectrum PharmaceuticalsChief Scientific OfficerActhar GelAssociate ProfessorMaryland SchoolClinical Pharmacology
Processa Pharmaceuticals, Inc. Appoints George Ng as Chief Executive Officer - Vimarsana News

Processa Pharmaceuticals, Inc. Appoints George Ng as Chief Executive Officer

Published: August 8, 2023

Processa Pharmaceuticals, Inc. announces that industry veteran George Ng has been appointed to serve as the Company's Chief Executive Officer and as a Board Director as of August 8, 2023. Dr. David...

Source: marketscreener.com
Related Topics:
United StatesDavid YoungJustin YorkeScilex Holding CoPfizer IncScilex Pharmaceuticals IncProcessa Pharmaceuticals IncSpectrum Pharmaceuticals IncSorrento Therapeutics IncBiodelivery Sciences International IncUniversity Of Notre Dame School LawUniversity Of CaliforniaCalidi Biotherapeutics IncAlpharma IncProcessa PharmaceuticalsChief Executive OfficerBoard DirectorProcessas Chairman JustinChief Operating OfficerScilex PharmaceuticalsSorrento TherapeuticsBiodelivery Sciences InternationalSpectrum PharmaceuticalsJuris DoctorNotre Dame School
Mindera Health™ Announces Change to Executive Leadership - Vimarsana News

Mindera Health™ Announces Change to Executive Leadership

Published: May 11, 2023

Ron Rocca to Become Chief Executive Officer...

Source: globenewswire.com
Related Topics:
San DiegoUnited StatesRon RoccaTowson UniversityPrometheus Laboratories IncHealth ScienceExagen IncMindera HealthMountain Group PartnersElan Pharmaceuticals IncAlpharma IncGeorge MahaffeyChief ExecutiveJoe CookManaging DirectorMountain GroupVice PresidentGeneral ManagerPrometheus LaboratoriesElan PharmaceuticalsPersonnel ManagementSan Diego AreaMindera HealthInd PxPrecision Medicine
Aquaculture Therapeutics Market is likely to reach US$ 4190.3 Mn by 2032, up from US$ 1634.8 Mn in 2022 - Vimarsana News

Aquaculture Therapeutics Market is likely to reach US$ 4190.3 Mn by 2032, up from US$ 1634.8 Mn in 2022

Published: November 8, 2022

Aquaculture Therapeutics Market is likely to reach US$ 4190.3 Mn by 2032, up from US$ 1634.8 Mn in 2022 | FMI

Source: pittsburghstar.com
Related Topics:
New YorkUnited StatesUnited Arab EmiratesNew ZealandPlot NoSulfadimethoxine OrmetoprimTunatech GmbMarket Research ExpertCompetition CompaniesMarket ResearchHydrogen PeroxideViaqua Therapeutics LtdGreater New York ChamberAlpharma IncTherapeutics MarketNorth AmericaLatin AmericaWestern EuropeEastern EuropeMiddle EastTech GmbhAqua Therapeutics LtdRest Of Eastern EuropePacific Excluding JapanTrending Reports
Opioid trial continues without Janssen; expert says oversupply caused crisis - Vimarsana News

Opioid trial continues without Janssen; expert says oversupply caused crisis

Published: April 18, 2022

CHARLESTON – Janssen settled with West Virginia, but the state trial continues against opioid suppliers Teva, Cephalon and Allergen continues.

Source: wvrecord.com
Related Topics:
United StatesNew JerseyWest VirginiaKing PharmaDerek SwopePatrick MorriseyAndrew KolodnyUs Drug Enforcement AdministrationCourtroom View NetworkAmerican Academy Of PainAmerican Pain FoundationBoone Circuit CourtKanawha Circuit CourtHeller School Brandeis UniversityAlpharma IncCenters For Disease ControlMass Litigation PanelOpioid Policy ResearchJudge Derek SwopeKanawha CircuitCourtroom ViewWest Virginia Attorney General Patrick MorriseyWashington StateWest Virginia Consumer ProtectionEnforcement Administration